granuloma annulare lesions

DBCOND0021285Hemic and Lymphatic DiseasesImmune System Diseases

granuloma annulare lesions is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Granuloma Annulare
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0025146ICD-10L92.0SNOMED CT156368000MedDRA10018692UMLSC0085074

What you can answer from here — as of October 22, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for granuloma annulare lesions share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In